Characterisation of the guanylate cyclase catalytic activity in irak3
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: FREIHAT, Lubna (Monash University, Drug discovery biology, Melbourne, Australia)
- Co-author(s): Wheeler, Janet I. (Monash University, Melbourne, Australia)
Manallack, David T (Monash University, Melbourne, Australia)
Irving, Helen R. (Monash University, Melbourne, Australia)
IRAK3 (interleukin-1 receptor associated kinase 3) is an important negative regulator of inflammation and is critical in maintaining homeostasis in the innate immune response. The selectivity of IRAK3 and its exact mechanism of action are not fully understood. IRAK3 was unearthed as a potential novel guanylate cyclase (GC) using a GC specific.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.